Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 85509-1075

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 85509-1075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Phoenix Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Ond4)

This is a description of a medication containing 4 mg of ondansetron hydrochloride per film-coated tablet. The usual dosage instructions are provided through scanning the package insert QR code. It is recommended to store the tablets in a tight, light-resistant container at temperatures between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The tablets should be protected from light. The product details include NDC# 85509-1075-3, containing 30 tablets and are manufactured by Aurobindo Pharma Limited and repackaged by PHOENIX RX LLC. The expiration date for the listed lot is July 10, 2026.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.